Pomalidomide is a life-saving medication used primarily in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. As the demand for effective cancer treatments grows, pomalidomide manufacturers play a crucial role in ensuring the availability of this important drug.
Pomalidomide is an oral medication that belongs to a class of drugs called immunomodulatory agents. It helps the immune system to detect and destroy cancer cells. Pomalidomide is often prescribed when other treatments, such as lenalidomide and bortezomib, are no longer effective. In addition to its role in treating multiple myeloma, it is also being studied for its potential use in other diseases, including certain autoimmune disorders.